Documented allergy to DMSO, mouse or bovine proteins, or iron.
Known allergy or intolerance to any component of belimumab, including human or murine proteins or monoclonal antibodies
History of allergy to mouse proteins
Known allergy to murine proteins or have had a documented anaphylactic reaction to any drug, or a known hypersensitivity to diphenhydramine or other antihistamines of similar chemical structure.
History of allergy to mouse proteins
History of allergy to mouse proteins
Patients who are known to have allergy to mouse proteins
History of allergy to mouse proteins
History of allergy to mouse proteins
History of prior ? grade 3 hypersensitivity reaction or any toxicity attributed to trastuzumab or murine proteins that warranted permanent cessation of these agents (applicable for Cohort 1 only).
Allergies or hypersensitivity to murine, chimeric, human or humanised proteins
History of severe environmental allergies or allergy to egg proteins
History of allergy to egg proteins
hypersensitivity to trastuzumab, murine proteins, fulvestrant, or to any of the excipients
Known anaphylaxis or IgE-mediated hypersensitivity to murine proteins or to any component of rituximab
History of allergy to murine proteins
History of allergy to murine proteins
History of allergy to mouse proteins
Known anaphylaxis or immunoglobulin E (IgE)-mediated hypersensitivity to murine proteins or to any component of rituximab
Known hypersensitivity to murine or chimeric antibodies or proteins
History of intolerance (including grade 3 or 4 infusion reactions) to murine proteins
Known anaphylaxis or IgE-mediated hypersensitivity to murine proteins or to any component of rituximab.
History of intolerance, including Grade 3 to 4 infusion reaction or hypersensitivity to trastuzumab or murine proteins or any components of the product
Patients with known hypersensitivity to mouse proteins (murine antibodies in ISOLEX) if receiving soybean agglutinin and E-rosetting (SBA-E) bone marrow, or chicken egg products
The patient has known hypersensitivity to bovine proteins
Patients with known hypersensitivity to mouse proteins (murine antibodies in ISOLEX) if receiving T-cell depleted (soybean lectin agglutination [SBA]-E)- bone marrow, or chicken egg products
Patient has a known hypersensitivity to dimethyl sulfoxide (DMSO) or murine or bovine proteins.
Known anaphylaxis or IgE-mediated hypersensitivity to murine proteins or to any component of rituximab (RituxanÂ®)
History of severe environmental allergies or allergy to egg proteins
Type I hypersensitivity or anaphylactic reactions to murine proteins or to previous infusion of rituximab
History of intolerance (including grade 3 or 4 infusion reaction) or hypersensitivity to trastuzumab or murine proteins
Known unmanageable allergies, hypersensitivity, intolerance to monoclonal antibodies, to murine, chimeric, human proteins or their excipients
Subjects allergic to infliximab, inactive components of infliximab, murine proteins and methylprednisolone
Prior history of hypersensitivity to milk proteins
Patients with a history of allergy to human proteins
Documented allergy to iron dextran or murine proteins
Prior exposure to murine proteins or chimeric antibodies
